Advertisement

TheBodyPRO.com Covers CROI 2017

News

Two-Drug HIV Treatment Regimens Effective in Latest Studies

March 8, 2017

This is really the first step in demonstrating that two-drug regimens can be as effective as three-drug regimens.

-- Kimberly Smith, M.D., M.P.H.

In an interview on behalf of IFARA at CROI 2017, Fred Schaich spoke with Kimberly Smith about the potential for treating HIV with only two instead of three antiretrovirals. The goal here is to develop effective drugs with the fewest side effects.

The two SWORD studies presented at CROI randomized virally suppressed participants to continue their three- or four-drug treatment regimen or to switch to a new regimen consisting of dolutegravir (Tivicay, DTG) plus rilpivirine (Edurant). HIV levels remained undetectable in 95% of those in either study arm, proving that a two-drug regimen can be as effective as one with more medications.

Over 20% of enrollees in these trials were women and more than 25% were over 50 years old. Researchers wanted the study population to represent the demographic characteristics of those living with HIV, Smith noted.

Watch the video to learn more:



About the panelist:

  • Kimberly Smith, M.D., M.P.H., ViiV Healthcare.

The video above has been posted on TheBodyPRO.com with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.


Related Stories

Two-Drug Regimen Shines in HIV Treatment Switch Study
New HIV Capsid Inhibitor Strongly Stops HIV Replication at Two Steps
Weekly Injections of Antibody PRO 140 Keep HIV Undetectable in 10 of 16 Patients



This article was provided by TheBodyPRO.com. It is a part of the publication The 24th Conference on Retroviruses and Opportunistic Infections.
 


No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement

The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.